• Pharmapedia: FDA Clears Robotic Blood-Draw System That Can Find Veins and Collect Blood on Its Own
    20 August 2026

    FDA Clears Robotic Blood-Draw System That Can Find Veins and Collect Blood on Its Own

    The U.S. Food and Drug Administration (FDA) has authorized Aletta, a first-of-its-kind standalone robotic device designed to draw blood from a patient’s arm without hands-on intervention by a phlebotomist.

    The authorization, announced on August 19, 2026, allows Aletta to be used in adults in outpatient settings under the supervision of a trained phlebotomist. According to the FDA, one trained phlebotomist can oversee up to three Aletta devices at the same time, potentially helping healthcare facilities manage shortages of trained blood-collection professionals.

  • 17 July 2026
    Call for Proposals for Establishment of “DBT-NIDAN Kendras” under the UMMID Network
    Clinical genetics services and Genetic Counseling: Evaluation of patients with suspected genetic disorders, Prenatal diagnostic facilities for ultrasonography and procedures like amniocentesis/chorionic villus sampling, Genetic Counseling of families with patients with genetic diseases, pregnant mothers carrying fetuses with high risk of genetic disorders et
  • 17 January 2026
    When Pills Talk Back: Inside MIT’s Swallowable Technology That Could Transform Medication Adherence
    For decades, one of medicines most stubborn challenges hasnt been discovering new drugs, its making sure patients actually take them. Missed doses, delayed schedules, and incomplete treatments quietly undermine even the most advanced therapies, contributing to hundreds of thousands of preventable deaths and billions of dollars in healthcare costs every year.
  • 1 January 2026
    Peptides in Cosmetics

    Vinay KumarVinay Kumar Singh. 
    Head-Formulation
    Kumar Organic Products Research Centre Pvt. Ltd.,
    Bengaluru
    Email : formulation_krc@kopresearchcentre.net

  • 17 December 2025
    Kopulan Strips-for Sublingual Administration of Active

    Vinay KumarVinay Kumar Singh. 
    Head-Formulation
    Kumar Organic Products Research Centre Pvt. Ltd.,
    Bengaluru
    Email : formulation_krc@kopresearchcentre.net

  • 27 November 2025
    Europe’s HIV Crisis: Over Half of Diagnoses Still Come Too Late, Undermining “End AIDS by 2030” Goal
    A new surveillance report for 2023 which was published in 2024, by ECDC and WHO/Europe reveals that across the WHO European Region, more than half of people newly diagnosed with HIV are identified at a late stage of infection. This pattern persists despite expanded testing efforts and renewed focus on prevention.
  • 5 September 2025
    A Glimpse of a Drug-Free Future for Type 1 Diabetes
    genetically modified pancreatic islet cells transplanted into a man with type 1 diabetes, without the need for immune-suppressing drugs. For twelve weeks, the cells survived, produced insulin, and functioned naturally.
  • 22 August 2025
    Department of atomic energy role in cancer research treatment
    Over the past few years, Department of Atomic Energy (DAE) has developed several key nuclear medicine ligands and targeted therapeutics towards national effort against cancer, especially in the areas of advanced treatment and research. To cater the demand for import substitute radiation-medicine in India, Department of Atomic Energy
  • 29 May 2025
    Global pharmaceutical industries are shifting towards biotechnological research
    The pharmaceutical world is changing fast, and biotech is right at the center of it. While traditional small-molecule drugs are still essential, we are seeing a real shift toward treatments like monoclonal antibodies, gene therapy, and even personalized medicine.
  • 27 May 2025
    Does India need five years for the B.Pharm course?

    In recent days, there has been growing discussion and a few articles advocating for the extension of the Bachelor of Pharmacy (B.Pharm) program in India from four years to five years. These calls are often based on the intent to strengthen the academic depth of the course, enhance clinical exposure, and align Indian pharmacy education with global standards. However, this proposal has sparked a mixed response within the academic and professional community.

Subscribe to Articles